Advertisement Pharmaceutical Business review - Page 8 of 5225 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
November 22, 2024

Dyadic receives grant from Gates Foundation for RSV antibody development

Dyadic International has received a $3m grant from the Bill & Melinda Gates Foundation to develop monoclonal antibodies (mAbs) for the treatment of respiratory syncytial virus (RSV) and malaria.

Continue
The $3m grant is to develop monoclonal antibodies for treatment of respiratory syncytial virus and malaria. Credit: National Institute of Allergy and Infectious Diseases on Unsplash.
November 21, 2024

Laekna partners with Lilly to develop obesity therapy

The partnership is set to concentrate on clinically assessing and developing the monoclonal antibody for treating obesity. Credit: Michał Parzuchowski on Unsplash.
November 20, 2024

FDA grants ODD to Ractigen Therapeutics’ RAG-21 for ALS treatment

The therapy is designed to combat one of the ALS subtypes, FUS-ALS by reducing FUS protein. Credit: JOSHUA COLEMAN on Unsplash.

Contracts

August 9, 2024

Bavarian Nordic secures $156.8m US vaccine deal

The vaccine is marketed under various brand names. Credit: Mathurin NAPOLY / matnapo on Unsplash.

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Harbour BioMed, Moderna partner on immunotherapies development

Deals

Deals July 15, 2024

Merck enhances ophthalmology portfolio with EyeBio acquisition

Pharmaceutical Business Review

Biocon signs licensing and supply deal for diabetes drug in Brazil

Q32 Bio concludes merger deal with Homology Medicines

Zuellig Pharma acquires Cialis and Alimta brands from Lilly

Popular

  1. Arrowhead Pharmaceuticals submits plozasiran NDA to treat FCS
  2. Numab Therapeutics and Kaken Pharmaceutical collaborate to develop ND081
  3. FDA to review Sanofi, Regeneron’s Dupixent sBLA for CSU
  4. Asha Therapeutics secures grant for ALS therapeutic development
  5. AstraZeneca and Daiichi Sankyo submit BLA to FDA for lung cancer treatment

PRESS RELEASES

Tosoh Bioscience – Separation & Purification Expands European Headquarters in Griesheim, Germany
Tosoh Bioscience – Separation & Purification Expands European Headquarters in Griesheim, Germany
BioSeparation Sustainable Biochromatography Forum ‒ Join Us in Vienna on 27 November 2024
BioSeparation Sustainable Biochromatography Forum ‒ Join Us in Vienna on 27 November 2024
Gerresheimer Gx Elite Vials: Best Drug Protection and Production Efficiency
Gerresheimer Gx Elite Vials: Best Drug Protection and Production Efficiency
Gerresheimer: EcoVadis Gold with Further Improved Score
Gerresheimer: EcoVadis Gold with Further Improved Score
Gerresheimer: Innovative Silicone Oil-Free Syringe Systems for Sensitive Ophthalmic Drugs
Gerresheimer: Innovative Silicone Oil-Free Syringe Systems for Sensitive Ophthalmic Drugs

Suppliers

Whitepapers

Saving Through Partnership and Innovation
Saving Through Partnership and Innovation
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Wound Care – Selecting the Right Antiseptic for Your Formulation
Wound Care – Selecting the Right Antiseptic for Your Formulation